
Pramila R. Anne'
Radiation Oncology
111 South 11th Street
Suite G-301
Philadelphia, PA 19107
Suite G-301
Philadelphia, PA 19107
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Adjuvant Chemotherapy ± Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head: Results of the Radiotherapy Random Assignment of NRG Oncology/RTOG 0848.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 15, 2026
Addressing Sexual Toxicity Among Cancer Survivors: Clinicians Challenges and Potential Interventions.
Journal: The American journal of hospice & palliative care
Published: May 08, 2026
Radiation Therapy for Pancreatic Cancer: An ASTRO Clinical Practice Guideline.
Journal: Practical radiation oncology
Published: March 25, 2026
Impact of prior sexual trauma on patient experience and comfort in breast cancer radiation therapy.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: February 27, 2026
Intimacy After Diagnosis: Navigating Sexual Health Conversations and Disparities Among Cancer Survivors.
Journal: The American journal of hospice & palliative care
Published: February 14, 2026
Evaluation of image quality in mobile cone-beam CT with dose modulation using automatic exposure control: A phantom study.
Journal: Journal of applied clinical medical physics
Published: April 16, 2025
Complete Pathologic Response to Gemcitabine and Oxaliplatin Chemotherapy After Prior Therapies in a Patient With Hepatocellular Carcinoma and Peritoneal Metastases Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Journal: World journal of oncology
Published: February 10, 2024
Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma.
Journal: Radiation oncology (London, England)
Published: December 08, 2023
A Pilot Study of Hepatic Irradiation with Yttrium-90 Microspheres Followed by Immunotherapy with Ipilimumab and Nivolumab for Metastatic Uveal Melanoma.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: January 13, 2022
Last Updated: 09/26/2026